{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:55:58Z","timestamp":1791168958997,"version":"4.1.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.nbd.2011.12.030","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T11:34:12Z","timestamp":1324726452000},"page":"243-254","source":"Crossref","is-referenced-by-count":56,"title":["Gene therapy for Huntington's disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Shilpa","family":"Ramaswamy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey H.","family":"Kordower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2011.12.030_bb0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1046\/j.1471-4159.1999.0730070.x","article-title":"Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons","volume":"73","author":"Akerud","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0010","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0361-9230(01)00775-4","article-title":"Neuroprotection by neurotrophins and GDNF family members in the excitotoxic model of Huntington's disease","volume":"57","author":"Alberch","year":"2002","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.nbd.2011.12.030_bb0015","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0020","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0166-2236(90)90107-L","article-title":"Functional architecture of basal ganglia circuits: neural substrates of parallel processing","volume":"13","author":"Alexander","year":"1990","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0025","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1073\/pnas.74.9.3767","article-title":"3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase","volume":"74","author":"Alston","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0030","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1073\/pnas.93.14.7346","article-title":"Ciliary neurotrophic factor protects striatal output neurons in an animal model of Huntington disease","volume":"93","author":"Anderson","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0035","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ng0893-398","article-title":"The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease","volume":"4","author":"Andrew","year":"1993","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0040","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0306-4522(97)00079-1","article-title":"Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease","volume":"81","author":"Araujo","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.030_bb0045","doi-asserted-by":"crossref","first-page":"10302","DOI":"10.1523\/JNEUROSCI.22-23-10302.2002","volume":"22","author":"Azzouz","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0050","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1089\/10430340050111377","article-title":"Neuroprotective gene therapy for Huntington's disease using a polymer encapsulated BHK cell line engineered to secrete human CNTF","volume":"11","author":"Bachoud-Levi","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0055","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/hum.1998.9.8-1181","article-title":"Selective and rapid uptake of adeno-associated virus type 2 in brain","volume":"9","author":"Bartlett","year":"1998","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0060","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb1000","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/321168a0","article-title":"Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid","volume":"321","author":"Beal","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.030_bb0065","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/JCP.0b013e3181b2ac0a","article-title":"Randomized controlled trial of atomoxetine for cognitive dysfunction in early Huntington disease","volume":"29","author":"Beglinger","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0070","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00705-008-0222-7","article-title":"Adeno-associated virus type 2 vectors: transduction and long-term expression in cerebellar Purkinje cells in vivo is mediated by the fibroblast growth factor receptor 1: bFGFR-1 mediates AAV2 transduction of Purkinje cells","volume":"153","author":"Belur","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0075","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1089\/10430349950016393","article-title":"Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transfer","volume":"10","author":"Bemelmans","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","article-title":"RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform","volume":"50","author":"Bennett","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0085","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1089\/cap.2006.16.525","article-title":"Effect of CX516, an AMPA-modulating compound, on cognition and behavior in fragile X syndrome: a controlled trial","volume":"16","author":"Berry-Kravis","year":"2006","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0090","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1089\/hum.2004.15.968","article-title":"Neuroprotective gene therapy for Huntington's disease, using polymer-encapsulated cells engineered to secrete human ciliary neurotrophic factor: results of a phase I study","volume":"15","author":"Bloch","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0095","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1128\/MCB.16.5.2151","article-title":"The full oncogenic activity of Ret\/ptc2 depends on tyrosine 539, a docking site for phospholipase Cgamma","volume":"16","author":"Borrello","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0885","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/jme.2010.041111","article-title":"The right not to know: the case of psychiatric disorders","volume":"37","author":"Bortolotti","year":"2011","journal-title":"J. Med. Ethics"},{"key":"10.1016\/j.nbd.2011.12.030_bb0105","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0110","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1089\/hum.2009.182","article-title":"Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors","volume":"21","author":"Boutin","year":"2010","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0115","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2005.11.057","article-title":"Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain","volume":"138","author":"Broekman","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.030_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/mds.22376","article-title":"Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine","volume":"24","author":"Brusa","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.030_bb0125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0169-328X(99)00217-X","article-title":"Localization of GDNF\/neurturin receptor (c-ret, GFRalpha-1 and alpha-2) mRNAs in postnatal rat brain: differential regional and temporal expression in hippocampus, cortex and cerebellum","volume":"73","author":"Burazin","year":"1999","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0130","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ymthe.2004.05.024","article-title":"Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system","volume":"10","author":"Burger","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0135","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1089\/hum.2005.16.781","article-title":"Recombinant adeno-associated viral vectors in the nervous system","volume":"16","author":"Burger","year":"2005","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/arclin\/5.3.287","article-title":"Aspects of procedural memory are differentially impaired in Huntington's disease","volume":"5","author":"Bylsma","year":"1990","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0145","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1523\/JNEUROSCI.21-01-00117.2001","article-title":"Expression of brain-derived neurotrophic factor in cortical neurons is regulated by striatal target area","volume":"21","author":"Canals","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0150","doi-asserted-by":"crossref","first-page":"7727","DOI":"10.1523\/JNEUROSCI.1197-04.2004","article-title":"Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease","volume":"24","author":"Canals","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0155","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1523\/JNEUROSCI.5071-04.2005","article-title":"Endothelial nitric oxide synthase regulates brain-derived neurotrophic factor expression and neurogenesis after stroke in mice","volume":"25","author":"Chen","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0160","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.bbrc.2005.02.024","article-title":"Sleeping Beauty-mediated down-regulation of huntingtin expression by RNA interference","volume":"329","author":"Chen","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2011.12.030_bb0165","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","article-title":"Immune responses to adenovirus and adeno-associated virus in humans","volume":"6","author":"Chirmule","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0170","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.molbrainres.2004.05.015","article-title":"Glial cell line-derived neurotrophic factor receptor GFRalpha1 is expressed in the rat striatum during postnatal development","volume":"127","author":"Cho","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0175","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/1566523054064968","article-title":"AAV hybrid serotypes: improved vectors for gene delivery","volume":"5","author":"Choi","year":"2005","journal-title":"Curr. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0180","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ajmg.b.30501","article-title":"Low brain-derived neurotrophic factor (BDNF) levels in serum of Huntington's disease patients","volume":"144","author":"Ciammola","year":"2007","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0185","first-page":"215","article-title":"Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease","volume":"47","author":"Ciarmiello","year":"2006","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.nbd.2011.12.030_bb0190","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1016\/S0021-9258(18)50574-3","article-title":"Inactivation of succinate dehydrogenase by 3-nitropropionate","volume":"254","author":"Coles","year":"1979","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0195","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1034\/j.1399-0004.2003.00093.x","article-title":"Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000","volume":"63","author":"Creighton","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0200","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1002\/mds.22809","article-title":"A pilot study using nabilone for symptomatic treatment in Huntington's disease","volume":"24","author":"Curtis","year":"2009","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.030_bb0205","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.neurobiolaging.2005.04.002","article-title":"RET expression does not change with age in the substantia nigra pars compacta of rhesus monkeys","volume":"27","author":"Dass","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2011.12.030_bb0210","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1006\/nbdi.2001.0388","article-title":"Neuroprotective effect of a CNTF-expressing lentiviral vector in the quinolinic acid rat model of Huntington's disease","volume":"8","author":"de Almeida","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.030_bb0215","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-11-81","article-title":"An adeno-associated viral vector transduces the rat hypothalamus and amygdala more efficient than a lentiviral vector","volume":"11","author":"de Backer","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0220","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuroscience.2007.11.044","article-title":"Cortical expression of brain derived neurotrophic factor and type-1 cannabinoid receptor after striatal excitotoxic lesions","volume":"152","author":"De March","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.030_bb0225","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1002\/jnr.21636","article-title":"Sustained striatal ciliary neurotrophic factor expression negatively affects behavior and gene expression in normal and R6\/1 mice","volume":"86","author":"Denovan-Wright","year":"2008","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0230","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.030_bb0235","doi-asserted-by":"crossref","first-page":"17204","DOI":"10.1073\/pnas.0708285104","article-title":"Therapeutic silencing of mutant huntingtin with siRNA attenuates striatal and cortical neuropathology and behavioral deficits","volume":"104","author":"DiFiglia","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0240","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/mt.2009.216","article-title":"Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates","volume":"18","author":"Dodiya","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0245","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1002\/ana.21569","article-title":"Sustained effects of nonallele-specific Huntingtin silencing","volume":"65","author":"Drouet","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0250","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2005.11.056","article-title":"GDNF family ligands display distinct action profiles on cultured GABAergic and serotonergic neurons of rat ventral mesencephalon","volume":"1069","author":"Ducray","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0890","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.biopsych.2006.11.034","article-title":"Psychiatric symptoms in Huntington's disease before diagnosis: the predict-HD study","volume":"62","author":"Duff","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0260","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.030_bb0265","doi-asserted-by":"crossref","first-page":"5168","DOI":"10.1523\/JNEUROSCI.16-16-05168.1996","article-title":"Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease","volume":"16","author":"Emerich","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0270","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/386395a0","article-title":"Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease","volume":"386","author":"Emerich","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2011.12.030_bb0895","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1089\/hum.2010.155","article-title":"Safety of liver gene transfer following peripheral intravascular delivery of adeno-associated virus (AAV)-5 and AAV-6 in a large animal model","volume":"22","author":"Favaro","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nbt.1515","article-title":"Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes","volume":"27","author":"Foust","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0285","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/mt.2008.50","article-title":"AAV vector-mediated RNAi of mutant huntingtin expression is neuroprotective in a novel genetic rat model of Huntington's disease","volume":"16","author":"Franich","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/jpet.110.167551","article-title":"Diminished activity-dependent brain-derived neurotrophic factor expression underlies cortical neuron microcircuit hypoconnectivity resulting from exposure to mutant huntingtin fragments","volume":"335","author":"Gambazzi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0295","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.nbd.2007.04.003","article-title":"AAV2-mediated delivery of human neurturin to the rat nigrostriatal system: long-term efficacy and tolerability of CERE-120 for Parkinson's disease","volume":"27","author":"Gasmi","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.030_bb0300","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/sj.mt.6300010","article-title":"Striatal delivery of neurturin by CERE-120, an AAV2 vector for the treatment of dopaminergic neuron degeneration in Parkinson's disease","volume":"15","author":"Gasmi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.cell.2004.06.018","article-title":"Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules","volume":"118","author":"Gauthier","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.030_bb0310","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1471-4159.2007.05137.x","article-title":"Brain-derived neurotrophic factor over-expression in the forebrain ameliorates Huntington's disease phenotypes in mice","volume":"105","author":"Gharami","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0315","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1460-9568.2006.04590.x","article-title":"Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain","volume":"23","author":"Gines","year":"2006","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0320","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/gt.2010.71","article-title":"BDNF regulation under GFAP promoter provides engineered astrocytes as a new approach for long-term protection in Huntington's disease","volume":"17","author":"Giralt","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0325","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2011.12.030_bb0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/sj.npp.1301444","article-title":"A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia","volume":"33","author":"Goff","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0335","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1046\/j.1471-4159.2001.00538.x","article-title":"Neuroprotection of striatal neurons against kainate excitotoxicity by neurotrophins and GDNF family members","volume":"78","author":"Gratacos","year":"2001","journal-title":"J. Neurochem."},{"issue":"Pt 4","key":"10.1016\/j.nbd.2011.12.030_bb0340","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1099\/0022-1317-73-4-961","article-title":"Detection of adeno-associated virus type 2 in human peripheral blood cells","volume":"73","author":"Grossman","year":"1992","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0345","doi-asserted-by":"crossref","first-page":"7874","DOI":"10.1128\/JVI.78.15.7874-7882.2004","article-title":"Adeno-associated virus site-specific integration and AAVS1 disruption","volume":"78","author":"Hamilton","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0350","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-008-1360-z","article-title":"Mechanisms underlying cognitive enhancement and reversal of cognitive deficits in nonhuman primates by the ampakine CX717","volume":"202","author":"Hampson","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.nbd.2011.12.030_bb0355","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1136\/bmj.300.6732.1089","article-title":"Genetic testing for Huntington's disease","volume":"300","author":"Harper","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.nbd.2011.12.030_bb0360","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1073\/pnas.0501507102","article-title":"RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model","volume":"102","author":"Harper","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0365","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","article-title":"Positron emission tomography in the early diagnosis of Huntington's disease","volume":"36","author":"Hayden","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0370","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0304-3940(91)90583-F","article-title":"Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease","volume":"133","author":"Hedreen","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2011.12.030_bb0375","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1037\/0735-7044.102.1.141","article-title":"Impaired learning of a motor skill in patients with Huntington's disease","volume":"102","author":"Heindel","year":"1988","journal-title":"Behav. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0380","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1227\/01.NEU.0000340682.06068.01","article-title":"Expression, bioactivity, and safety 1year after adeno-associated viral vector type 2-mediated delivery of neurturin to the monkey nigrostriatal system support cere-120 for Parkinson's disease","volume":"64","author":"Herzog","year":"2009","journal-title":"Neurosurgery"},{"key":"10.1016\/j.nbd.2011.12.030_bb0385","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1006\/exnr.1993.1111","article-title":"Transplantation of a polymer-encapsulated cell line genetically engineered to release NGF","volume":"122","author":"Hoffman","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0390","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","article-title":"Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with beta-tubulin: relevance to Huntington's disease","volume":"115","author":"Hoffner","year":"2002","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0395","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.1523\/JNEUROSCI.18-13-04929.1998","article-title":"Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons","volume":"18","author":"Horger","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0400","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","article-title":"Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial","volume":"66","author":"Huntington's disease Study Group","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0405","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1176\/appi.neuropsych.15.1.109","article-title":"On chorea. George Huntington, M.D.","volume":"15","author":"Huntington","year":"2003","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0410","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1006\/mthe.2001.0283","article-title":"Introduction of single base substitutions at homologous chromosomal sequences by adeno-associated virus vectors","volume":"3","author":"Inoue","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0415","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/gt.2008.23","article-title":"AAV-BDNF mediated attenuation of quinolinic acid-induced neuropathology and motor function impairment","volume":"15","author":"Kells","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0420","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archneurol.2009.334","article-title":"A randomized, placebo-controlled trial of latrepirdine in Huntington disease","volume":"67","author":"Kieburtz","year":"2010","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0425","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1006\/exnr.1997.6736","article-title":"Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors","volume":"150","author":"Klein","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0430","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ana.410160414","article-title":"Genetic testing in Huntington's disease","volume":"16","author":"Koller","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0435","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1126\/science.290.5492.767","article-title":"Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease","volume":"290","author":"Kordower","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.030_bb0440","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1073\/pnas.87.6.2211","article-title":"Site-specific integration by adeno-associated virus","volume":"87","author":"Kotin","year":"1990","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0445","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/jnnp.58.5.598","article-title":"Comparison of executive and visuospatial memory function in Huntington's disease and dementia of Alzheimer type matched for degree of dementia","volume":"58","author":"Lange","year":"1995","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0450","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/exnr.1997.6501","article-title":"Pharmacological activities of glial cell line-derived neurotrophic factor (GDNF): preclinical development and application to the treatment of Parkinson's disease","volume":"145","author":"Lapchak","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0455","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/jnr.21087","article-title":"Modeling the neurovascular niche","volume":"84","author":"Li","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0460","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/sj.gt.3300357","article-title":"Site-specific integration by adeno-associated virus: a basis for a potential gene therapy vector","volume":"4","author":"Linden","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0465","first-page":"161","article-title":"Studies on the epidemiology and etiology of moldy sugarcane poisoning in China","volume":"5","author":"Liu","year":"1992","journal-title":"Biomed. Environ. Sci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0470","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1212\/01.WNL.0000068165.07883.64","article-title":"IV amantadine improves chorea in Huntington's disease: an acute randomized, controlled study","volume":"60","author":"Lucetti","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0475","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1017\/S0317167100032212","article-title":"3-Nitropropionic acid-exogenous animal neurotoxin and possible human striatal toxin","volume":"18","author":"Ludolph","year":"1991","journal-title":"Can. J. Neurol. Sci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0480","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1523\/JNEUROSCI.5113-06.2007","article-title":"Brain-derived neurotrophic factor restores synaptic plasticity in a knock-in mouse model of Huntington's disease","volume":"27","author":"Lynch","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0485","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bbrc.2006.02.141","article-title":"rAAV-mediated shRNA ameliorated neuropathology in Huntington disease model mouse","volume":"343","author":"Machida","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2011.12.030_bb0490","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.030_bb0495","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1474-4422(08)70065-6","article-title":"Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial","volume":"7","author":"Marks","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0500","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1001\/archneur.64.1.116","article-title":"Specific psychiatric manifestations among preclinical Huntington disease mutation carriers","volume":"64","author":"Marshall","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0505","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0014-4886(03)00044-X","article-title":"Structural and functional neuroprotection in a rat model of Huntington's disease by viral gene transfer of GDNF","volume":"181","author":"McBride","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0510","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","author":"Boudreau","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0515","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0079-6123(02)38091-9","article-title":"Neuroprotection for Parkinson's disease using viral vector-mediated delivery of GDNF","volume":"138","author":"McBride","year":"2002","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0520","doi-asserted-by":"crossref","first-page":"9345","DOI":"10.1073\/pnas.0508875103","article-title":"Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease","volume":"103","author":"McBride","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0525","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0006-8993(95)01488-8","article-title":"Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector","volume":"713","author":"McCown","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0530","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jgm.885","article-title":"Immune responses to AAV in a phase I study for Canavan disease","volume":"8","author":"McPhee","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.nbd.2011.12.030_bb0535","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/ng824","article-title":"Chromosomal effects of adeno-associated virus vector integration","volume":"30","author":"Miller","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0540","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3109\/15563659509028924","article-title":"Moldy sugarcane poisoning\u2014a case report with a brief review","volume":"33","author":"Ming","year":"1995","journal-title":"J. Toxicol. Clin. Toxicol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0545","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1089\/10430340050015220","article-title":"Restoration of cognitive and motor functions by ciliary neurotrophic factor in a primate model of Huntington's disease","volume":"11","author":"Mittoux","year":"2000","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0550","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1523\/JNEUROSCI.22-11-04478.2002","article-title":"Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration","volume":"22","author":"Mittoux","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0555","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.brainres.2011.03.014","article-title":"Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors","volume":"1389","author":"Miyake","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0560","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/hmg\/ddq512","article-title":"Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice","volume":"20","author":"Mughal","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0565","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng1179","article-title":"AAV serotype 2 vectors preferentially integrate into active genes in mice","volume":"34","author":"Nakai","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0570","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","article-title":"Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes","volume":"81","author":"Nasir","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.030_bb0575","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1176\/appi.ajp.2007.06081266","article-title":"Morphology of the cerebral cortex in preclinical Huntington's disease","volume":"164","author":"Nopoulos","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0580","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1212\/WNL.60.1.69","article-title":"Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD","volume":"60","author":"Nutt","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0585","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.bbrc.2005.10.061","article-title":"siRNA-mediated inhibition of endogenous Huntington disease gene expression induces an aberrant configuration of the ER network in vitro","volume":"338","author":"Omi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.nbd.2011.12.030_bb0590","doi-asserted-by":"crossref","first-page":"6995","DOI":"10.1128\/JVI.77.12.6995-7006.2003","article-title":"Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding","volume":"77","author":"Opie","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0595","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.biopsych.2005.06.003","article-title":"Brain structure in preclinical Huntington's disease","volume":"59","author":"Paulsen","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0600","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1128\/JVI.78.12.6344-6359.2004","article-title":"Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain","volume":"78","author":"Peden","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0605","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/mt.2008.284","article-title":"Striatal readministration of rAAV vectors reveals an immune response against AAV2 capsids that can be circumvented","volume":"17","author":"Peden","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0610","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/sj.gt.3300358","article-title":"Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters","volume":"4","author":"Peel","year":"1997","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0615","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/mds.870050202","article-title":"Huntington's disease in Venezuela: 7years of follow-up on symptomatic and asymptomatic individuals","volume":"5","author":"Penney","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.030_bb0620","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(00)00074-9","article-title":"Neurturin protects striatal projection neurons but not interneurons in a rat model of Huntington's disease","volume":"98","author":"Perez-Navarro","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.030_bb0625","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1460-9568.1999.00433.x","article-title":"Intrastriatal grafting of a GDNF-producing cell line protects striatonigral neurons from quinolinic acid excitotoxicity in vivo","volume":"11","author":"Perez-Navarro","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0630","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0306-4522(96)00336-3","article-title":"Glial cell line-derived neurotrophic factor protects striatal calbindin-immunoreactive neurons from excitotoxic damage","volume":"75","author":"Perez-Navarro","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2011.12.030_bb0635","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1046\/j.1471-4159.2000.0752190.x","article-title":"Brain-derived neurotrophic factor, neurotrophin-3, and neurotrophin-4\/5 prevent the death of striatal projection neurons in a rodent model of Huntington's disease","volume":"75","author":"Perez-Navarro","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0640","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.cub.2009.03.030","article-title":"Five siRNAs targeting three SNPs may provide therapy for three-quarters of Huntington's disease patients","volume":"19","author":"Pfister","year":"2009","journal-title":"Curr. Biol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0645","doi-asserted-by":"crossref","first-page":"5411","DOI":"10.1128\/JVI.76.11.5411-5421.2002","article-title":"Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis","volume":"76","author":"Philpott","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0650","doi-asserted-by":"crossref","first-page":"12381","DOI":"10.1073\/pnas.182430299","article-title":"A p5 integration efficiency element mediates Rep-dependent integration into AAVS1 at chromosome 19","volume":"99","author":"Philpott","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0655","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1111\/j.1471-4159.2005.03047.x","article-title":"Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease","volume":"93","author":"Pineda","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0660","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/sj.gt.3302847","article-title":"Neuroprotection by GDNF-secreting stem cells in a Huntington's disease model: optical neuroimage tracking of brain-grafted cells","volume":"14","author":"Pineda","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0665","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00004583-199604000-00020","article-title":"Regional brain enlargement in autism: a magnetic resonance imaging study","volume":"35","author":"Piven","year":"1996","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0670","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.expneurol.2004.12.009","article-title":"Lentiviral gene delivery of GDNF into the striatum of R6\/2 Huntington mice fails to attenuate behavioral and neuropathological changes","volume":"193","author":"Popovic","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0675","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.nbd.2008.12.005","article-title":"Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's disease","volume":"34","author":"Ramaswamy","year":"2009","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.030_bb0680","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.nbd.2007.01.003","article-title":"Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's disease","volume":"26","author":"Ramaswamy","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2011.12.030_bb0685","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jnnp.2004.036806","article-title":"Incidence and mutation rates of Huntington's disease in Spain: experience of 9years of direct genetic testing","volume":"76","author":"Ramos-Arroyo","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2011.12.030_bb0690","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1089\/10430340260355383","article-title":"Dose-dependent neuroprotective effect of ciliary neurotrophic factor delivered via tetracycline-regulated lentiviral vectors in the quinolinic acid rat model of Huntington's disease","volume":"13","author":"Regulier","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0695","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0700","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ymthe.2005.05.006","article-title":"Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6\/1 Huntington's disease transgenic mice","volume":"12","author":"Rodriguez-Lebron","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0705","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/mds.20979","article-title":"Diffusion tensor imaging in presymptomatic and early Huntington's disease: selective white matter pathology and its relationship to clinical measures","volume":"21","author":"Rosas","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.030_bb0710","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1172\/JCI45130","article-title":"Oligonucleotide therapeutic approaches for Huntington disease","volume":"121","author":"Sah","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.nbd.2011.12.030_bb0715","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.1002\/j.1460-2075.1991.tb04964.x","article-title":"Targeted integration of adeno-associated virus (AAV) into human chromosome 19","volume":"10","author":"Samulski","year":"1991","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2011.12.030_bb0720","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3171\/2010.8.JNS091583","article-title":"Recombinant adeno-associated virus type 2 pseudotypes: comparing safety, specificity, and transduction efficiency in the primate striatum. Laboratory investigation","volume":"114","author":"Sanchez","year":"2011","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.nbd.2011.12.030_bb0725","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ymthe.2003.12.005","article-title":"Striatal delivery of rAAV-hAADC to rats with preexisting immunity to AAV","volume":"9","author":"Sanftner","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0730","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/jcs.00786","article-title":"Novel functions and signalling pathways for GDNF","volume":"116","author":"Sariola","year":"2003","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0735","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nbt0909-804","article-title":"The neonatal blood\u2013brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9","volume":"27","author":"Saunders","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0740","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0169-328X(94)90106-6","article-title":"Glial cell-line derived neurotrophic factor (GDNF) mRNA upregulation in striatum and cortical areas after pilocarpine-induced status epilepticus in rats","volume":"26","author":"Schmidt-Kastner","year":"1994","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0745","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cne.10938","article-title":"Evidence for progression in frontal cortical pathology in late-stage Huntington's disease","volume":"468","author":"Selemon","year":"2004","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0750","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/mds.870130420","article-title":"Huntington's disease confirmed by genetic testing in five African families","volume":"13","author":"Silber","year":"1998","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2011.12.030_bb0755","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knockin mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2011.12.030_bb0760","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber's congenital amaurosis is safe and effective through 1.5years after vector administration","volume":"18","author":"Simonelli","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0765","doi-asserted-by":"crossref","first-page":"9013","DOI":"10.1523\/JNEUROSCI.2747-08.2008","article-title":"Intrabodies binding the proline-rich domains of mutant huntingtin increase its turnover and reduce neurotoxicity","volume":"28","author":"Southwell","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0770","doi-asserted-by":"crossref","first-page":"13589","DOI":"10.1523\/JNEUROSCI.4286-09.2009","article-title":"Intrabody gene therapy ameliorates motor, cognitive, and neuropathological symptoms in multiple mouse models of Huntington's disease","volume":"29","author":"Southwell","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0775","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1083\/jcb.124.1.149","article-title":"Cerebroglycan: an integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation","volume":"124","author":"Stipp","year":"1994","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0780","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","article-title":"Microglial activation in presymptomatic Huntington's disease gene carriers","volume":"130","author":"Tai","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.nbd.2011.12.030_bb0785","doi-asserted-by":"crossref","first-page":"21209","DOI":"10.1074\/jbc.M102615200","article-title":"Phosphorylation of a novel myosin binding subunit of protein phosphatase 1 reveals a conserved mechanism in the regulation of actin cytoskeleton","volume":"276","author":"Tan","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0790","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/hum.2006.178","article-title":"Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain","volume":"18","author":"Taymans","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0795","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","author":"The Huntington's Disease Collaborative Research Group","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.nbd.2011.12.030_bb0800","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pneurobio.2006.11.004","article-title":"Nucleocytoplasmic trafficking and transcription effects of huntingtin in Huntington's disease","volume":"83","author":"Truant","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0805","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/hum.2007.116","article-title":"Identification and allele-specific silencing of the mutant huntingtin allele in Huntington's disease patient-derived fibroblasts","volume":"19","author":"van Bilsen","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0810","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/978-3-642-46870-4_18","article-title":"Signal transduction by the receptor tyrosine kinase Ret","volume":"154","author":"van Weering","year":"1998","journal-title":"Recent Results Cancer Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0815","doi-asserted-by":"crossref","first-page":"37445","DOI":"10.1074\/jbc.M110.125542","article-title":"Mutant huntingtin alters cell fate in response to microtubule depolymerization via the GEF-H1-RhoA-ERK pathway","volume":"285","author":"Varma","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0820","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.gt.3302011","article-title":"Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain","volume":"10","author":"Wang","year":"2003","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0825","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.neures.2005.06.021","article-title":"Clinico-pathological rescue of a model mouse of Huntington's disease by siRNA","volume":"53","author":"Wang","year":"2005","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0900","doi-asserted-by":"crossref","DOI":"10.1038\/gt.2011.49","article-title":"The influence of epileptic neuropathology and prior peripheral immunity on CNS transduction by rAAV2 and rAAV5","author":"Weinberg","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2011.12.030_bb0835","doi-asserted-by":"crossref","first-page":"23619","DOI":"10.1074\/jbc.271.39.23619","article-title":"Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase","volume":"271","author":"Worby","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2011.12.030_bb0840","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.neuro.2009.03.008","article-title":"Protective effects of brain-derived neurotrophic factor against neurotoxicity of 3-nitropropionic acid in rat cortical neurons","volume":"30","author":"Wu","year":"2009","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0845","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/089771503767168528","article-title":"GDNF and BDNF alter the expression of neuronal NOS, c-Jun, and p75 and prevent motoneuron death following spinal root avulsion in adult rats","volume":"20","author":"Wu","year":"2003","journal-title":"J. Neurotrauma"},{"key":"10.1016\/j.nbd.2011.12.030_bb0850","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.1523\/JNEUROSCI.1637-10.2010","article-title":"BDNF overexpression in the forebrain rescues Huntington's disease phenotypes in YAC128 mice","volume":"30","author":"Xie","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2011.12.030_bb0855","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1212\/WNL.36.2.244","article-title":"Huntington's disease in Venezuela: neurologic features and functional decline","volume":"36","author":"Young","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2011.12.030_bb0860","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.expneurol.2003.09.002","article-title":"Long-term lentiviral-mediated expression of ciliary neurotrophic factor in the striatum of Huntington's disease transgenic mice","volume":"185","author":"Zala","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2011.12.030_bb0865","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ng1095-155","article-title":"Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue","volume":"11","author":"Zeitlin","year":"1995","journal-title":"Nat. Genet."},{"key":"10.1016\/j.nbd.2011.12.030_bb0870","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1126\/science.1059581","article-title":"Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease","volume":"293","author":"Zuccato","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.nbd.2011.12.030_bb0875","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.phrs.2005.01.001","article-title":"Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery","volume":"52","author":"Zuccato","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.nbd.2011.12.030_bb0880","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1750-3639.2007.00111.x","article-title":"Systematic assessment of BDNF and its receptor levels in human cortices affected by Huntington's disease","volume":"18","author":"Zuccato","year":"2008","journal-title":"Brain Pathol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111004050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996111004050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T04:07:41Z","timestamp":1640146061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996111004050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":177,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0969996111004050"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2011.12.030","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}